Sharon E. Roberg-Perez Esq.

Robins Kaplan LLP
Roberg-Perez, Sharon

Sharon Roberg-Perez is a Principal in the Intellectual Property and Technology Litigation Group at Robins Kaplan LLP and serves as a member of the advisory board of Bloomberg BNA's Life Sciences Law & Industry Report. She is an M.I.T-trained Ph.D. who leverages over a decade of experience working as a molecular biologist in her legal practice. She serves on the firm’s diversity committee and has been an instructor in the firm’s Exceptional Advocate Training Program.

Dr. Roberg-Perez’s practice is focused on biotechnology and medical device patent litigation and licensing. She is also registered to practice before the U.S. Patent & Trademark Office. In the courtroom, she has represented both plaintiffs and defendants in cases involving technologies such as genotyping, DNA fingerprinting, transcatheter heart valves, ICDs, spinal implants, personalized content delivery via smartphones or web browsers, and cosmetic formulations. She has significant experience crafting case strategy, as well as running complex cases and developing claim construction, infringement and validity positions.

Ms. Roberg-Perez received her B.A. from Wellesley College, her Ph.D. from the Massachusetts Institute of Technology and her J.D. from the University of St. Thomas School of Law.